Aprea Therapeutics (APRE)
(Delayed Data from NSDQ)
$3.24 USD
+0.09 (2.85%)
Updated Sep 16, 2024 11:42 AM ET
4-Sell of 5 4
F Value D Growth A Momentum F VGM
Earnings News For APRE
-
Aprea Therapeutics, Inc. (APRE) Reports Q2 Loss, Tops Revenue Estimates
-
Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Aprea Therapeutics Reports First quarter 2024 Financial Results and Provides a Business Update
-
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
-
Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
-
Aprea Therapeutics Reports Second Quarter 2023 Financial Results and Provides Update on Business Operations
-
Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business Operations
-
Aprea Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Update on Business Operations
-
Aprea Therapeutics Reports Third Quarter 2022 Financial Results and Provides Update on Business Operations